• Home

    • Infection Prevention

    Photo 38458680 © Nakornkhai | Dreamstime.com
    Dreamstime Xxl 38458680
    Janette Wider
    Aug. 25, 2023
    Industry leaders address challenges that remain
    ID 119972999 © Jarun011 | Dreamstime.com
    rsv
    ID 71156821 © R. Gino Santa Maria / Shutterfree, Llc | Dreamstime.com
    dreamstime_xl_71156821
    ID 113230282 © Juan Moyano | Dreamstime.com
    hiv_prep
    ID 271266944 © Yee Xin Tan | Dreamstime.com
    hospital_associated_infections
    ID 32161147 © Fasphotographic | Dreamstime.com
    measles

    Infection Prevention

    ID 179931168 © Pop Nukoonrat | Dreamstime.com
    hospital_infection_2
    ID 197617498 © Feverpitched | Dreamstime.com
    covid_vaccine_5
    ID 111949353 © Artinun Prekmoung | Dreamstime.com
    antibiotics_5
    ID 211028415 © Josieelias | Dreamstime.com
    long_covid_2
    ID 185236108 © Josepalbert13 | Dreamstime.com
    infection_control
    ID 246355144 © Andrey Popov | Dreamstime.com
    dreamstime_xl_246355144
    ID 349141731 © Rochu2008 | Dreamstime.com
    flu_season
    ID 352967700 © Fr3ank33 | Dreamstime.com
    norovirus
    Matt MacKenzie
    June 6, 2025
    Traditionally, the GII.4 genotype of the virus drove most outbreaks, but the GII.17 genotype has been responsible for most cases in the last year or so.
    ID 206743014 © Thodonal | Dreamstime.com
    mrna_vaccine_2
    Matt MacKenzie
    June 4, 2025
    The new type of vaccine both contains less mRNA than other mRNA vaccines on the market, and is more adaptable and broadly protective.
    ID 155685936 | Healthcare © Leigh Prather | Dreamstime.com
    mmr_4
    Matt MacKenzie
    June 4, 2025
    78% of the approximately 2,000 counties studied showed a decline in MMR coverage from 2017 to 2024.
    ID 281959520 © Zelwanka | Dreamstime.com
    rsv_vaccine_2
    Matt MacKenzie
    May 30, 2025
    The organization suggests two vaccine products to protect infants from the leading cause of acute lower respiratory infections in children globally.
    ID 299333998 © Mohamed Ahmed Soliman | Dreamstime.com
    hhs_3
    Matt MacKenzie
    May 30, 2025
    The company announced that trial results for the vaccine were promising, as H5N1 continues to circulate in animals in the U.S.